Federal Circuit Reverses Jury’s Infringement Ruling in LabCorp vs. Qiagen, Citing Claim Construction Errors
The U.S. Court of Appeals for the Federal Circuit in Washington, D.C., has overturned a previous ruling by a district court in a significant patent infringement case involving Laboratory Corp. of America Holdings (LabCorp) and Qiagen Sciences, LLC. The appellate court found that the jury’s conclusions regarding patent infringement were not backed by adequate evidence and that the district court had improperly allowed the jury to make determinations on claim construction. LabCorp possesses two patents focused on methods for preparing DNA samples for sequencing, aiming to enhance whole-genome sequencing techniques. The dispute arose when LabCorp … Read more